Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Prenatal and early life exposure to air pollutants associated with toddler allergies

A new article in Annals of Allergy, Asthma and Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology shows a significant association between multiple prenatal and early life exposures to indoor pollutants and the degree of allergic sensitivity in 2-year-olds.

5 Dec 2019

Chronic disease prevention could help curb the opioid epidemic

Preventing chronic disease could help curb the opioid epidemic, according to research from the University of Georgia.

5 Dec 2019

Lung imaging studies of non-identical twins with asthma deepen understanding of the disease

Two lung imaging studies from Western University, including one performed in non-identical twin patients with life-long asthma, have shown that airway defects in the lungs of asthmatic patients are like thumbprints - they have a unique pattern and maintain that pattern over time.

4 Dec 2019

New technology developed for treatment of children suffering from respiratory diseases

A new technology to unblock and remove secretions from the respiratory tract of children has been developed as part of a collaboration between researchers at Ben-Gurion University of the Negev and its affiliated Soroka University Medical Center, Cincinnati Children's Hospital Medical Center, and the University of Cincinnati.

4 Dec 2019

Common cold virus could infect fetus via placenta

According to researchers, the common cold viruses are capable of infecting human placental cells and may thus transmit the infection to the fetus in the womb during pregnancy. The new study was published in the journal PLOS ONE, and provides the first concrete proof that this type of carriage is possible.

3 Dec 2019

Aspirin can be considered an effective and safe option to treat acute migraines

According to a new report in The American Journal of Medicine, published by Elsevier, aspirin can be considered an effective and safe option to other, more expensive medications to treat acute migraines as well as prevent recurrent attacks.

3 Dec 2019

Researchers propose aspirin as possible treatment option for patients with migraine

Migraine headache is the third most common disease in the world affecting about 1 in 7 people. More prevalent than diabetes, epilepsy and asthma combined, migraine headaches are among the most common and potentially debilitating disorders encountered by primary health care providers.

3 Dec 2019

Health organizations urge people to get vaccinated against the flu

Health organizations are urging people to get their flu shot soon to protect themselves during the upcoming influenza season.

28 Nov 2019

State-of-the-art expert reviews provide insights into vitamin D research

Vitamin D is essential for human health. Although much is known about its important role in bone metabolism and in certain areas of non-skeletal health, there are many open questions and topics of debate.

27 Nov 2019

FDA-approved anti-inflammatory drug delays onset of ALS in mice

The cause of amyotrophic lateral sclerosis (ALS)--a disabling neurodegenerative disease that affects nerve cells in the brain and spinal cord and leads to weakened muscles and early death--is not fully understood, but accumulating evidence suggests that inflammatory processes may play a role in the initiation and progression of the condition.

27 Nov 2019

Research could offer new hope for the prevention, treatment of deep vein thrombosis

New University of Birmingham research funded by the British Heart Foundation could improve treatments for a potentially deadly condition that affects tens of thousands of people in the UK each year.

26 Nov 2019

Looking for the source: new routes for allergy treatment

A new multinational study has reported a very full account of the B lymphocytes that produce group E antibodies, also called IgE (Immunoglobulin E), that are behind allergic reactions, which are common in up to a third of the world’s population.

26 Nov 2019

Study about cells producing group E antibodies would help fight against allergies

Researchers of Sechenov University together with their colleagues from Russia and Austria summarized everything known about cells producing group E antibodies

25 Nov 2019

Glaucoma risk increased by air pollution

The more polluted the air, the higher the risk is that those who live in that area will develop glaucoma, says an interesting new study from the UK, published today in the journal Investigative Ophthalmology and Visual Science.

25 Nov 2019

UMass Lowell researcher receives $1 million grant for asthma prevention research

A UMass Lowell researcher who works to alleviate asthma in senior citizens has received $1 million from the U.S. Department of Housing and Urban Development to advance his work.

22 Nov 2019

Tips for avoiding strain and injury after yard work

Just as playing football or golf can injure your body, the twisting, turning, bending and reaching involved in raking and using leaf blowers and other yard equipment that is so common this time of year can also cause pain and injury.

22 Nov 2019

Efforts to move the needle on flu shot rates get stuck

It's free and available everywhere. Yet most Americans skip the annual flu shot - with the number of dispensed vaccines barely changed in the past decade, despite government removal of cost and access obstacles.

21 Nov 2019

Air pollution associated with memory decline and Alzheimer's-like brain atrophy

Women in their 70s and 80s who were exposed to higher levels of air pollution experienced greater declines in memory and more Alzheimer's-like brain atrophy than their counterparts who breathed cleaner air, according to USC researchers.

20 Nov 2019

PCORI Board approves $70 million to support projects designed to improve care for health conditions

The Patient-Centered Outcomes Research Institute Board of Governors today approved $70 million to fund 21 studies and related projects designed to improve care for health conditions that impose high burdens on patients, their families and the healthcare system.

19 Nov 2019

Dopamine may worsen lung inflammation in asthma

A new study on a mouse model of asthma shows that nerve cells producing dopamine, a neurotransmitter, signal T cells in the body to promote inflammation due to allergic reactions in the lungs during childhood but not in adult mice.

19 Nov 2019

Asthma News and Research

Further Reading

Prenatal and early life exposure to air pollutants associated with toddler allergies

Chronic disease prevention could help curb the opioid epidemic

Lung imaging studies of non-identical twins with asthma deepen understanding of the disease

New technology developed for treatment of children suffering from respiratory diseases

Common cold virus could infect fetus via placenta

Aspirin can be considered an effective and safe option to treat acute migraines

Researchers propose aspirin as possible treatment option for patients with migraine

Health organizations urge people to get vaccinated against the flu

State-of-the-art expert reviews provide insights into vitamin D research

FDA-approved anti-inflammatory drug delays onset of ALS in mice

Research could offer new hope for the prevention, treatment of deep vein thrombosis

Looking for the source: new routes for allergy treatment

Study about cells producing group E antibodies would help fight against allergies

Glaucoma risk increased by air pollution

UMass Lowell researcher receives $1 million grant for asthma prevention research

Tips for avoiding strain and injury after yard work

Efforts to move the needle on flu shot rates get stuck

Air pollution associated with memory decline and Alzheimer's-like brain atrophy

PCORI Board approves $70 million to support projects designed to improve care for health conditions

Dopamine may worsen lung inflammation in asthma

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News